Previous studies have shown that increased parathyroid hormone (PTH) In vivo, a lineage tracing model subjected mice with endothelial-specific GFP fluorescence to 33 chronic PTH infusion showed a marked increase in the aortic expression of chondrocyte 34 markers, and confocal microscopy revealed the endothelial origin of cells expressing 35 chondrocyte markers in the aorta after PTH infusion. Furthermore, this in vitro study 36 showed that PTH enhanced the nuclear localization of β-catenin in ECs, whereas, β-catenin 37 siRNA or DKK1, an inhibitor of β-catenin nuclear translocation, attenuated the upregulation 38 of EndMT-associated and chondrogenic markers induced by PTH. In summary, our study 39 demonstrated that elevated PTH could induce the transition of ECs to chondrogenic cells via 40 EndMT, possibly mediated by the nuclear translocation of β-catenin. 41
Introduction 45
Vascular calcification (VC) is a frequent complication of chronic kidney disease (CKD) and is 46 associated with an increased risk of cardiovascular and all-cause mortality (27, 30) . 47 Numerous investigations have demonstrated that VC is a cell-regulated process with 48 similarities to bone formation, driven by osteochondrogenic cells (27, 34) . Recently, 49 emerging evidence has further revealed that endochondral bone formation initiated by the 50 presence of chondrocytes is a characteristic hallmark of VC in animal models with chronic 51 renal failure (CRF) and in human aorta specimens from transplant donors (23, 24, 42 ). These 52 findings showed that the accumulation of ectopic chondrogenic cells underlies the progression 53 of VC in CKD. 54 Previously, smooth muscle cells, mesenchymal stem cells and pericytes were considered to be 55 the major precursors of ectopic chondrogenic cells in calcified vessels (5, 25, 31) . In recent 56 studies, endothelial cells (ECs) have been demonstrated to participate in tissue calcification 57 by providing osteochondrogenic cells via the endothelial-to-mesenchymal transition (EndMT) 58 (8, 21, 33, 38) . 59 Elevated parathyroid hormone (PTH) levels are common in patients with CKD with the 60 decline of renal function due to the development of secondary hyperparathyroidism (2) . 61 Although the importance of PTH in mineral metabolism is well recognized, a series of studies 62 has recently suggested that PTH could directly induce endothelial dysfunction and contribute 63 to VC (6, (26) (27) (28) (29) . Nevertheless, the underlying mechanisms remain largely unclear. Our 64 recent experiments have found that PTH could induce EndMT and contribute to the 65 progression of cardiac fibrosis in uremic rats (36). However, whether ECs that underwent 66 7 Our previous dose-finding studies revealed that PTH induces EndMT in primary human aortic 133 ECs in a concentration-and time-dependent manner. Based on this result, we treated aortic 134 ECs with 10 -7 mol/L PTH for 48 h to observe the expression of EndMT-related markers. The 135 results of real-time PCR and western blot showed that PTH treatment led to a significant 136 decrement in the mRNA and protein expression of CD31 and an increase in the expression of 137 FSP1 and α-SMA (Fig. 1A-E) . Confocal microscopy detected that cells treated with PTH 138 acquired FSP1 staining and lost CD31 staining compared with control cells (Fig. 1F) . 139
EndMT induces chondrogenic potential in ECs 140
We next assessed the differentiation capability of ECs that undergo EndMT. Western blot 141 analysis indicated that the expressions of the chondrocyte specific markers SOX9 and Col2A1 142 were significantly increased in PTH-treated cells compared with controls ( Fig. 2A-B) . 
Lineage tracing reveals the endothelial-to-chondrogenic transition in aortas 144
following PTH-infusion 145 To further observe the effect of elevated PTH on the transition of the ECs to a chondrocyte 146 phenotype, an in vivo lineage tracing experiment was performed. We crossed inducible 147
Tie2-Cre mice with mT/mG mice to obtain tamoxifen-inducible Tie2-Cre + mT/mG mice in 148 which EGFP is expressed under the control of the endothelial-specific Tie2 promoter. 149
Because PTH (1-34) is the shortest fragment with the same biological effect as the intact PTH, 150
we infused PTH (1-34) into these mice and controls and evaluated the expression of 151 chondrocyte markers. As illustrated in Fig. 3A -B, alcian blue staining exhibited the 152 conspicuously enhanced deposition of chondrocyte proteoglycans in aortic media from the 153 PTH-infused group compared with controls (CTL) (arrows, Fig. 3B ). As determined by 154 8 immunohistochemical analysis, chondrocyte markers (SOX9 and Col2A1) protein were 155 dramatically increased in aortas from the PTH-infusion group compared with CTLs ( Fig.  156 3C-F). Furthermore, staining with anti-SOX9 antibody (blue) revealed EGFP-positive 157 endothelial cells (green) that co-expressed chondrocyte specific markers SOX9 (arrows, cyan, 158 Fig. 3G-H) . EGFP was only detected in the aortic endothelium in the control mice. These 159 results suggested the endothelial origin of ectopic chondrocytes in the aorta from mice with 160 continuous PTH-infusion. 
Nuclear translocation of β-catenin mediates PTH-induced EndMT in aortic ECs 162
To gain further insight into the mechanisms involved in EndMT triggered by PTH in ECs, we 163 further examined the nuclear expression of β-catenin in cells treated with or without PTH. 164 As shown in Fig. 4A -B, the nuclear protein levels of β-catenin were induced in a 165 concentration-dependent manner in ECs treated with PTH, suggesting the nuclear 166 translocation of β-catenin. And immunefluorescence staining of β-catenin also showed a 167 nuclear relocation of β-catenin in the cultured ECs stimulated with PTH (Fig. 4C ). Since 168 canonical Wnt signaling culminates in β-catenin nuclear translocation, these data suggest that 169 PTH can activate the canonical Wnt/β-catenin pathway. 170 Next, we further evaluated whether canonical Wnt/β-catenin signaling activation is required 171 for PTH-induced EndMT in our experiments. ECs were incubated with PTH in the presence 172 or absence of β-catenin siRNA or the canonical Wnt/β-catenin signaling inhibitor dickkopf-1 173 (DKK1). As shown in Fig. 5 , down-regulation of β-catenin by siRNA significantly reduced 174 the PTH-triggered induction of EndMT-related markers.
In addition, DKK1, the 175 prototypical inhibitor of canonical Wnt signaling, also abolished the expression of EndMT-related markers in response to treatment with elevated PTH (Fig. 6) . 177 3.5 Blockade of EndMT by suppressing the canonical Wnt/β-catenin pathway prevents 178 the expression of chondrocyte markers in cells 179 We further examined whether β-catenin siRNA or DKK1 could prevent the expression of 180 chondrocyte markers in cells undergoing EndMT induced by PTH. And we found a 181 significantly decreased protein level of chondrocyte markers in cells treated with β-catenin 182 siRNA ( Fig. 7A-B) or DKK1 (Fig. 7C-D 
Discussion 185
The mechanisms responsible for VC are complex. They typically require a decrease of The elevation of serum PTH concentration is a common condition in CKD with the decline of 208 glomerular filtration rate. In this study, chronic infusion of PTH to mouse showed a 209 Tie2-positive chondrocytes in aortic samples by immunofluorescence analysis, suggesting an 210 endothelial origin of ectopic cartilage in the aorta (Fig. 3) . Moreover, the in vitro studies 211 further showed that expression of chondrocyte markers SOX9 and COL2A1 were 212 significantly increased in PTH-treated cells compared with the control (Fig. 2) . These data 213 clearly indicated that elevated PTH could induce the endothelial to chondrogenic 214 phenotypical transition in ECs. Considering the involvement of PTH in the progression of 215 uremic calcified lesions (6,26), this PTH-induced phenotypic alteration in ECs might 216 represent a novel mechanism contributing to VC in uremia. 217 Previous studies showed that animal receiving continuous PTH infusion developed media 218 calcification (25). In our in vivo study, the cartilage proteoglycan is also mainly located in 219 aortic media (Fig.3) . Recently, investigations have demonstrated that EndMT is a source of 220 11 osteochondeogenic cells in media calcification (38, 39) . Yao et al. showed that the expression 221 of endothelial markers was detected deep in the calcified media (39). Furthermore, they found 222 that cell co-expressing endothelial and osteochondrogenic marker was highly abnormal and 223 detached from the internal elastic lamina to penetrate into the media as visualized by phase 224 contrast and transmission electron microscopy in calcified aortas. In lesions of aortic 225 calcification in Mgp-deficient mice, the internal elastic lamina was gradually degraded and 226
ECs undergoing EndMT were oriented from the luminal side toward the aortic medial layer 227 and calcifying lesional areas (38). Besides, numerous studies have disclosed that ECs could 228 acquire the ability to migrate through EndMT (13, 35) . Taken together, all these findings 229 suggest that EndMTs involves in media calcification in part by penetrating into the medial 230 tissue and further trans-differentiating into osteochondrogenic cells. And in the present study, 231
we observed the co-expression of endothelial marker (EGFP-positive cells) and chondrocyte 232 marker (SOX9) in tunica media in PTH-infusion mice. Although the exact mechanisms are 233 unclear, it might be associated with the cellular motility endued by EndMT. 234 As shown by data from this study, cells undergoing EndMT acquire the transdifferentiation 235 potential to become chondrocytes. Using siRNA or pharmacological approaches to inhibit 236 PTH-induced EndMT in cultured aortic ECs attenuated the expression of chondrocyte 237 markers SOX9 and COL2A1 in these cells (Fig. 7) EndMT during the progression of cerebral cavernous malformation (CCM) disease, increased 254 β-catenin nuclear translocation and transcriptional signaling could also be detected (19) . 255 Moreover, Li et al. found that Wnt/β-catenin pathway mediated EndMT in diabetic kidney 256 disease (17). In this study, we showed that PTH-induced EndMT in aortic ECs was also 257 accompanied by the nuclear translocation of β-catenin. Conversely, the knockdown of 258 β-catenin with siRNA or blockade of its nuclear translocation with the specific inhibitor 259 DKK1 significantly attenuated the expression of EndMT-markers induced by PTH in ECs 260 (Fig. 5 & Fig. 6 
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